BEDSON S.A. – Trademark Portfolio

Entity Type: 03

BEDSON S.A. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FOSBAC. The owner is based in Buenos Aires.

Ruta 8, Km. 47, La Lonja Pilar

Buenos Aires B163DIK , AR

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BEDSON
BEDSON
Cancelled 2009
FOSBAC
FOSBAC
Registered 2008
FOSBAC
FOSBAC
Abandoned 2003
BEDSON
BEDSON
Abandoned 2003

Trademark Classifications

BEDSON S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does BEDSON S.A. have?

BEDSON S.A. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.

What trademark classes does BEDSON S.A. file in?

BEDSON S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BEDSON S.A.'s most well-known trademarks?

BEDSON S.A.'s registered trademark portfolio includes well-known marks such as FOSBAC. These are among 1 currently registered trademark in the portfolio.

What is BEDSON S.A.'s trademark registration success rate?

BEDSON S.A. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.